Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors

ανά Gupta, Jalaj, Igea, Ana, Papaioannou, Marilena, Lopez-Casas, Pedro Pablo, Llonch, Elisabet, Hidalgo, Manuel, Gorgoulis, Vassilis G., Nebreda, Angel R.
Τόπος έκδοσης Oncotarget (2015)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET

ανά Hernández-Agudo, Elena, Mondejar, Tamara, Soto-Montenegro, Maria Luisa, Megías, Diego, Mouron, Silvana, Sanchez, Jesus, Hidalgo, Manuel, Lopez-Casas, Pedro Pablo, Mulero, Francisca, Desco, Manuel, Quintela-Fandino, Miguel
Τόπος έκδοσης Mol Oncol (2015)

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models

ανά Céspedes, María Virtudes, Guillén, María José, López-Casas, Pedro Pablo, Sarno, Francesca, Gallardo, Alberto, Álamo, Patricia, Cuevas, Carmen, Hidalgo, Manuel, Galmarini, Carlos María, Allavena, Paola, Avilés, Pablo, Mangues, Ramón
Τόπος έκδοσης Dis Model Mech (2016)

MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management

ανά Morcillo, Miguel Ángel, García de Lucas, Ángel, Oteo, Marta, Romero, Eduardo, Magro, Natalia, Ibáñez, Marta, Martínez, Alfonso, Garaulet, Guillermo, Arroyo, Alicia G., López-Casas, Pedro Pablo, Hidalgo, Manuel, Mulero, Francisca, Martínez-Torrecuadrada, Jorge
Τόπος έκδοσης Contrast Media Mol Imaging (2018)

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data

ανά Piñeiro-Yáñez, Elena, Reboiro-Jato, Miguel, Gómez-López, Gonzalo, Perales-Patón, Javier, Troulé, Kevin, Rodríguez, José Manuel, Tejero, Héctor, Shimamura, Takeshi, López-Casas, Pedro Pablo, Carretero, Julián, Valencia, Alfonso, Hidalgo, Manuel, Glez-Peña, Daniel, Al-Shahrour, Fátima
Τόπος έκδοσης Genome Med (2018)